Search Results - "Terwel, Sofie"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Calcium homeostasis and low-frequency magnetic and electric field exposure: A systematic review and meta-analysis of in vitro studies by Golbach, Lieke A., Portelli, Lucas A., Savelkoul, Huub F.J., Terwel, Sofie R., Kuster, Niels, de Vries, Rob B.M., Verburg-van Kemenade, B.M.Lidy

    Published in Environment international (01-07-2016)
    “…Low frequency magnetic field (LF MF) exposure is recurrently suggested to have the ability to induce health effects in society. Therefore, in vitro model…”
    Get full text
    Journal Article
  2. 2

    Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children by Teshome, Emily M, Andang'o, Pauline E A, Osoti, Victor, Terwel, Sofie R, Otieno, Walter, Demir, Ayşe Y, Prentice, Andrew M, Verhoef, Hans

    Published in BMC medicine (28-04-2017)
    “…We aimed to show the non-inferiority of home fortification with a daily dose of 3 mg iron in the form of iron as ferric sodium ethylenediaminetetraacetate…”
    Get full text
    Journal Article
  3. 3

    Late diagnosis of HIV infection in asymptomatic patients by Kundro, Mariana A, Terwel, Sofie R, Toibaro, Javier J, Viloria, Guillermo A, Losso, Marcelo H

    Published in Medicina (Buenos Aires) (01-01-2016)
    “…Recent findings from the START Trial provided evidence that early initiation of antiretroviral treatment should be implemented as the global standard of care…”
    Get full text
    Journal Article
  4. 4

    Comparison of home fortification with two iron formulations among Kenyan children: Rationale and design of a placebo-controlled non-inferiority trial by Teshome, Emily M, Otieno, Walter, Terwel, Sofie R, Osoti, Victor, Demir, Ayşe Y, Andango, Pauline E.A, Prentice, Andrew M, Verhoef, Hans

    “…Abstract Introduction Home fortification powders containing iron and other micronutrients have been recommended by World Health Organisation to prevent iron…”
    Get full text
    Journal Article
  5. 5

    Opportunities and challenges associated with the evaluation of chimeric antigen receptor T cells in real-life by McGrath, Eoin, Chabannon, Christian, Terwel, Sofie, Bonini, Chiara, Kuball, Jurgen

    Published in Current opinion in oncology (01-09-2020)
    “…PURPOSE OF REVIEWWith the approval of the first chimeric antigen receptor (CAR)-T cell products on the market, the European Medicines Agency (EMA) required…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    CAR-T CELLS: How does the EBMT registry monitor European activities, identify hurdles and prepare for changes in regulations by Chabannon, Christian, Lemaitre, Jessica, Peffault de Latour, Régis, Neven, Bénédicte, Bay, Jacques-Olivier, Robin, Marie, Kuball, Jurgen, Terwel, Sofie, Mohty, Mohamad, Yakoub-Agha, Ibrahim

    Published in Bulletin du cancer (01-10-2021)
    “…CAR-T Cells are gene therapy medicinal products, a subcategory of Advanced Therapy Medicinal Products as defined in the EC Regulation 1394/2007. They may…”
    Get full text
    Journal Article
  9. 9
  10. 10

    CAR-T cells : comment le registre de l’EBMT monitore les activités en Europe, identifie les contraintes et prépare l’évolution des régulations by Chabannon, Christian, Lemaitre, Jessica, Peffault de Latour, Régis, Neven, Bénédicte, Bay, Jacques-Olivier, Robin, Marie, Kuball, Jurgen, Terwel, Sofie, Mohty, Mohamad, Yakoub-Agha, Ibrahim

    Published in Bulletin du cancer (01-10-2021)
    “…Les CAR-T cells sont des médicaments de thérapie génique, une sous-catégorie des médicaments de thérapie innovante définis par le Règlement européen 2007/1394…”
    Get full text
    Journal Article